TROMETHAMINE
TROMETHAMINE is indicated for the treatment of Metabolic Acidosis; Cardiac Arrest.
Details
- Status
- Prescription
- First Approved
- 2024-12-09
- Routes
- INJECTION
- Dosage Forms
- SOLUTION
TROMETHAMINE Approval History
What TROMETHAMINE Treats
2 indicationsTROMETHAMINE is approved for 2 conditions since its original approval in 2024. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Metabolic Acidosis
- Cardiac Arrest
TROMETHAMINE Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
Drugs Similar to TROMETHAMINE
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
TROMETHAMINE FDA Label Details
Indications & Usage
TROMETHAMINE is indicated for the treatment of Metabolic Acidosis; Cardiac Arrest.
Looking for the branded version?
THAM
Full clinical data, patents, trials, and competitive landscape for tromethamine.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.